Tag: BCR-ABL Inhibitors

Home / BCR-ABL Inhibitors

Categories

Asciminib is approved by the USFDA for newly diagnosed chronic myeloid leukemia

 On October 29, 2024, the Food and Drug Administration approved asciminib (Scemblix, Novartis AG) for adults who have just been diagnosed with Philadelphia chromosome-positive chronic myeloid leukemi...
bcr-abl-inhibitors

Scan the code